Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

University of Toronto

$132,724.00

Engineering DNAzyme-gold nanoparticle diagnostic device

FY 2018-19

Summary
Mosquitos carry many infectious pathogens that can significantly affect a patient's health as*well as other people that the patients come into contact with. Currently, there is a major global*scare with the transmission of the Zika virus, which has been implicated in cerebral brain*malformations among fetuses and newborns. Given advances in transportation vehicles,*there is a significant risk of the virus being imported back to countries where the mosquitos*carry it are found. There remains an urgent need to develop simple methods to rapidly*diagnose Zika virus infection as it continues to spread to new locations. Rapid diagnosis in*areas with reduced access to testing laboratories will allow appropriate management of*pregnant women who become infected and implement control measures as the virus spreads*to new, often remote areas. Here, in this project, our aim is to develop a unique colour-based*test using nanotechnology components to be able to rapidly diagnose patients that are*presenting symptoms for the Zika virus, as well as two other important mosquito borne*viruses, dengue and chikungunya virus. Testing of the 3 viruses is important to determine*proper treatment, as patients infected with either of three viruses may present the same*symptoms. We will further develop a smartphone readout system that enables the*quantification and monitoring of transmission of Zika virus. A team consisting of an engineer*and two medical doctors is assembled to build and test this diagnostic device. Our*commercial partners have the infrastructure to build the device and reagents, test the*diagnostic systems, and to globally sell and distribute the technology for use in patient care.
Program
Collaborative Health Research Projects
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
523436-2018
Name nom
Chan, Warren
Department département
Biomaterials and Biomedical Engineering, Inst. of (IBBME)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
132724
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
1
Application title
Engineering DNAzyme-gold nanoparticle diagnostic device
Keyword
NSERC
Application summary
Mosquitos carry many infectious pathogens that can significantly affect a patient's health as*well as other people that the patients come into contact with. Currently, there is a major global*scare with the transmission of the Zika virus, which has been implicated in cerebral brain*malformations among fetuses and newborns. Given advances in transportation vehicles,*there is a significant risk of the virus being imported back to countries where the mosquitos*carry it are found. There remains an urgent need to develop simple methods to rapidly*diagnose Zika virus infection as it continues to spread to new locations. Rapid diagnosis in*areas with reduced access to testing laboratories will allow appropriate management of*pregnant women who become infected and implement control measures as the virus spreads*to new, often remote areas. Here, in this project, our aim is to develop a unique colour-based*test using nanotechnology components to be able to rapidly diagnose patients that are*presenting symptoms for the Zika virus, as well as two other important mosquito borne*viruses, dengue and chikungunya virus. Testing of the 3 viruses is important to determine*proper treatment, as patients infected with either of three viruses may present the same*symptoms. We will further develop a smartphone readout system that enables the*quantification and monitoring of transmission of Zika virus. A team consisting of an engineer*and two medical doctors is assembled to build and test this diagnostic device. Our*commercial partners have the infrastructure to build the device and reagents, test the*diagnostic systems, and to globally sell and distribute the technology for use in patient care.